
ONCO
Healthcare · Biotechnology · $2.2M market cap
$3.21+0.18 (+5.9%)Nov 13, 4:10 PM EST
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2023
EPS trend, 90 days to now · 30-day revisions 0 up, 0 down
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 12, 2026 | Time not confirmed | — | — | — |
| Aug 13, 2026 | Time not confirmed | — | -1.28 | — |
| May 11, 2026 | Time not confirmed | — | 0.00 | — |
| Mar 12, 2026 | Time not confirmed | — | 0.00 | — |
| Nov 28, 2025 | Time not confirmed | — | -6.25 | — |
| Aug 29, 2025 | Time not confirmed | — | -4.18 | — |
| May 30, 2025 | Time not confirmed | — | -45.44 | — |
| Mar 6, 2025 | Time not confirmed | — | -2.93 | — |
| Nov 7, 2024 | Time not confirmed | — | -249.08 | — |
| Aug 12, 2024 | Time not confirmed | — | -2191.49 | — |
| May 20, 2024 | After the close | -0.21 | -0.50 | -139.0% |
| Mar 7, 2024 | Time not confirmed | -0.21 | -3404.00 | -1620854.7% |
| Nov 17, 2023 | After the close | -32300.02 | -52700.03 | -63.2% |
Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. It has a license agreement with LabCorp to develop and commercialize Proclarix and other products; and with…
| Aug 14, 2023 | Time not confirmed | -0.18 | -612.00 | -339900.0% |
| May 12, 2023 | After the close | -34850.02 | -30600.02 | +12.2% |
| Mar 9, 2023 | Time not confirmed | -0.20 | -680.00 | -339900.0% |
| Nov 10, 2022 | Time not confirmed | -0.27 | -918.00 | -339900.0% |
| Aug 15, 2022 | Time not confirmed | — | -0.36 | — |
| May 13, 2022 | Time not confirmed | — | -0.34 | — |
| Feb 23, 2022 | Time not confirmed | — | -0.12 | — |
| Nov 5, 2021 | Time not confirmed | — | -0.05 | — |